tiprankstipranks
Advertisement
Advertisement

MANE Stock Latest News

Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164
RatingsBuy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164
14d ago
MANE
Veradermics sees cash runway into 2030
PremiumThe Fly
Veradermics sees cash runway into 2030
15d ago
MANE
Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year
PremiumThe Fly
Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year
15d ago
MANE
Veradermics registers to sell 16.77M shares of common stock
PremiumThe Fly
Veradermics registers to sell 16.77M shares of common stock
19d ago
MANE
Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study
PremiumThe Fly
Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study
1M ago
MANE
Veradermics price target raised to $160 from $135 at Citi
PremiumThe FlyVeradermics price target raised to $160 from $135 at Citi
1M ago
MANE
B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
Premium
Market News
B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
1M ago
MANE
Veradermics rises 13.9%
Premium
The Fly
Veradermics rises 13.9%
1M ago
MANE
Fifteen new option listings on July 15th
PremiumThe Fly
Fifteen new option listings on July 15th
1M ago
AKTS
AVBC
Veradermics announces results from Phase 2 trial of VDPHL01
PremiumThe Fly
Veradermics announces results from Phase 2 trial of VDPHL01
1M ago
MANE
Veradermics initiated with a Buy at B. Riley
PremiumThe Fly
Veradermics initiated with a Buy at B. Riley
1M ago
MANE
Veradermics price target raised to $182 from $138 at Jefferies
PremiumThe Fly
Veradermics price target raised to $182 from $138 at Jefferies
2M ago
MANE
Veradermics initiated with an Outperform at LifeSci Capital
PremiumThe FlyVeradermics initiated with an Outperform at LifeSci Capital
2M ago
MANE
Veradermics initiated with a Buy at Needham
Premium
The Fly
Veradermics initiated with a Buy at Needham
3M ago
MANE
Premium
Ratings
Veradermics Initiated at Buy on Late-Stage Oral Hair Loss Therapy VDPHL01 and Multi-Billion-Dollar Peak Sales Potential
3M ago
MANE
Veradermics price target raised to $135 from $120 at Citi
PremiumThe Fly
Veradermics price target raised to $135 from $120 at Citi
3M ago
MANE
PremiumCompany Announcements
Veradermics Faces Financing Risk as Cashless Pre-Funded Warrants Offer Little to No Capital Infusion
3M ago
MANE
Veradermics reports Q1 net income ($27.2M) vs ($12.4M) last year
PremiumThe Fly
Veradermics reports Q1 net income ($27.2M) vs ($12.4M) last year
4M ago
MANE
PremiumCompany Announcements
Veradermics Boosts Capital Through Public Offering and Warrants
4M ago
8K
MANE
Veradermics 3.84M share Secondary priced at $100.00
PremiumThe FlyVeradermics 3.84M share Secondary priced at $100.00
4M ago
MANE
Veradermics announces offering of 3.35M shares of common stock
Premium
The Fly
Veradermics announces offering of 3.35M shares of common stock
4M ago
MANE
Veradermics files to sell 3.35M shares of common stock
Premium
The Fly
Veradermics files to sell 3.35M shares of common stock
4M ago
MANE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >